11 Best Gene Therapy Stocks to Buy According to Analysts
Gene therapy is a medical approach that entails changing or modifying genes to treat or prevent disease.
Ionis Pharmaceuticals Inc (IONS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 2,817,347 | $98,494,451 | +22% | 2.02% |
| 2. | 78,966,000 | $76,503,241 | +193% | 1.57% | |
| 3. | Citadel Investment Group Ken Griffin | 2,165,916 | $75,720,424 | +440% | 0.01% |
| 4. | Deep Track Capital David Kroin | 1,933,928 | $67,610,123 | -13% | 2.52% |
| 5. | 50,000,000 | $48,440,750 | +20% | 2.43% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $36.23 | 2,500 | Director | 35,219 | 2024-12-23 | Filing | |
| $36.20 | 2,500 | Director | 32,719 | 2024-12-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $28.37 | 680 | Officer | 56,660 | 2025-04-16 | Filing | |
| $28.36 | 3,016 | Officer | 11,199 | 2025-04-16 | Filing | |
| $28.40 | 3,928 | Officer | 31,926 | 2025-04-16 | Filing | |
| $32.32 | 140 | Officer, Director | 180,980 | 2025-03-11 | Filing | |
| $32.35 | 1,207 | Officer | 56,245 | 2025-02-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 30,793,000 | $29,939,757 | 0.96% | |
| 2. | 25,689,000 | $24,944,019 | 0.11% | |
| 3. | 544,633 | $16,431,584 | 0% | |
| 4. | 500,451 | $15,098,608 | 0.06% | |
| 5. | 328,904 | $9,340,874 | 1.21% |
News See All
12 Most Promising Biotech Stocks According to Wall Street Analysts
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q4 2024 Earnings Call Transcript
Operator: Good morning, and welcome to Ionis Pharmaceuticals, Inc.'s Fourth Quarter and Full Year 2024 Financial Results Conference Call. As a reminder, this call is being recorded.
12 Most Oversold Healthcare Stocks to Buy Now
Healthcare costs and spending have been rising in the US. The Centers for Medicare & Medicaid Services reported that healthcare spending in the US reached $4.9 trillion in 2023, up 7.5% from 2022.
10 Top Insider Stock Buys And Sells In January
Ever heard of the “January effect?” In case you haven’t, a “January effect” is considered a phenomenon in the stock market where stock prices, most commonly of small-cap stocks, rise in the ...
10 Mid-Cap Stocks Insiders Are Selling Recently
Why should investors analyze insider trading activity? Insiders, or people in high positions within a company—such as executives and directors—can have crucial insights into the company’s strategic...
12 Best Healthcare Stocks to Buy According to Analysts
McKinsey reported that, since 2019, the US healthcare industry witnessed significant financial pressure.
12 Biotech Stocks with the Biggest Upside Potential
While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.
10 Worst Performing Biotech Stocks in 2024
Biotechnology stocks are among the most volatile in the market due to their high risk.
10 Best Genomics Stocks To Buy Right Now
Genomics is the study of genes and how they function.
Billionaire Hedge Funds
